These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 19855133)
1. Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. Chen L; Periquet M; Wang X; Negro A; McLean PJ; Hyman BT; Feany MB J Clin Invest; 2009 Nov; 119(11):3257-65. PubMed ID: 19855133 [TBL] [Abstract][Full Text] [Related]
2. The role of phosphorylation in synucleinopathies: focus on Parkinson's disease. Cavallarin N; Vicario M; Negro A CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):471-81. PubMed ID: 20522010 [TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Chen L; Feany MB Nat Neurosci; 2005 May; 8(5):657-63. PubMed ID: 15834418 [TBL] [Abstract][Full Text] [Related]
4. Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation. Lassen LB; Thomsen MS; Basso E; Füchtbauer EM; Füchtbauer A; Outeiro TF; Jensen PH; Moos T Cells; 2022 Nov; 11(22):. PubMed ID: 36429099 [TBL] [Abstract][Full Text] [Related]
5. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice. Schell H; Hasegawa T; Neumann M; Kahle PJ Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424 [TBL] [Abstract][Full Text] [Related]
7. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease. Kleinknecht A; Popova B; Lázaro DF; Pinho R; Valerius O; Outeiro TF; Braus GH PLoS Genet; 2016 Jun; 12(6):e1006098. PubMed ID: 27341336 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of alpha-synuclein characteristic of synucleinopathy lesions is recapitulated in alpha-synuclein transgenic Drosophila. Takahashi M; Kanuka H; Fujiwara H; Koyama A; Hasegawa M; Miura M; Iwatsubo T Neurosci Lett; 2003 Jan; 336(3):155-8. PubMed ID: 12505616 [TBL] [Abstract][Full Text] [Related]
9. Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity. Ihara M; Yamasaki N; Hagiwara A; Tanigaki A; Kitano A; Hikawa R; Tomimoto H; Noda M; Takanashi M; Mori H; Hattori N; Miyakawa T; Kinoshita M Neuron; 2007 Feb; 53(4):519-33. PubMed ID: 17296554 [TBL] [Abstract][Full Text] [Related]
10. Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting inclusion formation. Du G; Liu X; Chen X; Song M; Yan Y; Jiao R; Wang CC Mol Biol Cell; 2010 Jul; 21(13):2128-37. PubMed ID: 20444973 [TBL] [Abstract][Full Text] [Related]
11. Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease. Zhou W; Milder JB; Freed CR J Biol Chem; 2008 Apr; 283(15):9863-70. PubMed ID: 18238775 [TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease. McFarland NR; Fan Z; Xu K; Schwarzschild MA; Feany MB; Hyman BT; McLean PJ J Neuropathol Exp Neurol; 2009 May; 68(5):515-24. PubMed ID: 19525899 [TBL] [Abstract][Full Text] [Related]
13. Dynamic reversibility of α-synuclein serine-129 phosphorylation is impaired in synucleinopathy models. Ramalingam N; Brontesi L; Jin SX; Selkoe DJ; Dettmer U EMBO Rep; 2023 Dec; 24(12):e57145. PubMed ID: 37870370 [TBL] [Abstract][Full Text] [Related]
14. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans. Kuwahara T; Koyama A; Koyama S; Yoshina S; Ren CH; Kato T; Mitani S; Iwatsubo T Hum Mol Genet; 2008 Oct; 17(19):2997-3009. PubMed ID: 18617532 [TBL] [Abstract][Full Text] [Related]
15. Investigating the presence of doubly phosphorylated α-synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases. Fayyad M; Erskine D; Majbour NK; Vaikath NN; Ghanem SS; Sudhakaran IP; Abdesselem H; Lamprokostopoulou A; Vekrellis K; Morris CM; Attems J; El-Agnaf OMA Brain Pathol; 2020 Jul; 30(4):831-843. PubMed ID: 32324926 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of α-synuclein protein at Ser-129 reduces neuronal dysfunction by lowering its membrane binding property in Caenorhabditis elegans. Kuwahara T; Tonegawa R; Ito G; Mitani S; Iwatsubo T J Biol Chem; 2012 Mar; 287(10):7098-109. PubMed ID: 22232559 [TBL] [Abstract][Full Text] [Related]
18. Tyrosine 136 phosphorylation of α-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2. Sano K; Iwasaki Y; Yamashita Y; Irie K; Hosokawa M; Satoh K; Mishima K Acta Neuropathol Commun; 2021 Nov; 9(1):182. PubMed ID: 34772466 [TBL] [Abstract][Full Text] [Related]
19. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models. Sato H; Kato T; Arawaka S Rev Neurosci; 2013; 24(2):115-23. PubMed ID: 23314528 [TBL] [Abstract][Full Text] [Related]